Phase II Study of SOX Regimen in Patients with Resected Gastric Cancer
Phase 2
- Conditions
- Gastric cancer patient after curative resection
- Registration Number
- JPRN-jRCT2080222076
- Lead Sponsor
- Yakult Honsha Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Histologically confirmed stage III gastric cancer after D2 lymph node resection by a standard procedure with a diagnosis of R0.
Exclusion Criteria
- Lack of complete recovery from the effects of major surgery
- History of treatment other than surgery for the underlying disease
- Serious hypersensitivity to fluoropyrimidine or platinum compounds, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tolerability
- Secondary Outcome Measures
Name Time Method Safety